MediPharm Labs (TSE:LABS) has released an update.
MediPharm Labs, a leader in pharmaceutical-quality cannabis products, has scheduled the release of its Q2 2024 financial results for August 14, 2024. Following the release, the company’s executive team will host a conference call and webcast to discuss the performance. The announcement underscores MediPharm’s commitment to transparency and leadership in the cannabinoid industry.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
